Search Results

• • 284 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Menveo

  From:Formulary (Vol. 47, Issue 3) Peer-Reviewed

  Mar. 201261 words Brief article 1320LMeningococcal [Groups A, C, Y, and W-135] oligasaccharide diphtheria [CRM.sub.197] conjugate vaccine (Menveo, Novartis) for expanded use in infants and toddlers from 2 months of age. The CRL indicated FDA has completed...

• Meningococcal serogroup B vaccines: will they live up to expectations?

  Authors:Wendell D. Zollinger, Jan T. Poolman, and Martin C.J. MaidenFrom:Expert Review of Vaccines (Vol. 10, Issue 5) Peer-Reviewed

  May 20112,237 words Report 1480LAuthor(s): Wendell D Zollinger 1 , Jan T Poolman [[dagger]] 2 , Martin CJ Maiden 3 Keywords : antigenic variation; factor H-binding protein; fHbp; MenB; OMV; outer membrane vesicle; PorA; Porin A The...

• Immunisation programme puts stress on nurses: as the country's largest-ever immunisation campaign gets underway in the Auckland region with massive publicity, nurses need to ensure they are able to cope with the multiple pressures such a campaign brings

  Author:Chris MillarFrom:Kai Tiaki: Nursing New Zealand (Vol. 10, Issue 7) Peer-Reviewed

  Aug. 2004718 words Article RECENT REPORTING in the media about the licensing of the Meningococcal B vaccine (MeNZB[TM]) and the subsequent launch of the vaccination programme has highlighted a number of issues for nurses. The MeNZB[TM] has been...

• Mortality in severe meningococcal disease. (Community child health, public health and epidemiology)

  Authors:K Thorburn, P Baines, A Thomson, and C A HartFrom:Archives of Disease in Childhood (Vol. 85, Issue 5) Peer-Reviewed

  Nov. 20012,705 words Article Abstract Aim--To evaluate mortality of critically ill children admitted with meningococcal disease. Methods--Prospective study of all children admitted to a regional paediatric intensive care unit (PICU) between...

• Accident and Emergency/Intensive Care

  From:Archives of Disease in Childhood (Vol. 84, Issue 4) Peer-Reviewed

  Apr. 20014,652 words Article G1 IS GLASGOW MENINGOCOCCAL SEPTICAEMIA PROGNOSTIC SCORE (GMSPS) USEFUL IN PREDICTING MORTALITY IN SEVERE MENINGOCOCCAL SEPTIC SHOCK? S. Thayyil-Sudhan, M. Shenoy, D.K. Luyt. Paediatric Intensive Care Unit, Leiceseer...

• Neurodevelopmental outcome in meningococcal disease: a case--control study

  Authors:J M Fellick, J A Sills, O Marzouk, C A Hart, R W I Cooke, and A P J ThomsonFrom:Archives of Disease in Childhood (Vol. 85, Issue 1) Peer-Reviewed

  July 20013,764 words Article Abstract Aims--To determine long term neurodevelopmental outcome following the spectrum of meningococcal infection. Methods--Between 1988 and 1990, 152 cases of meningococcal disease were recruited; 139 survived....

• Extremity pain and refusal to walk in children with invasive meningococcal disease

  Authors:Stanley H. Inkelis, Daniel O'Leary, Vincent J. Wang, Richard Malley, Martha K. Nicholson, and Nathan KuppermannFrom:Pediatrics (Vol. 110, Issue 1) Peer-Reviewed

  July 2002318 words Abstract Objective. Early recognition of invasive meningococcal disease in children may be difficult. Extremity pain and refusal to walk (extremity symptoms) are uncommonly mentioned as clinical findings in children who present...

• Early treatment with parenteral penicillin in meningococcal disease

  Authors:Keith Cartwright, Sheena Reilly, Diana White, and James StuartFrom:British Medical Journal (Vol. 305, Issue 6846) Peer-Reviewed

  July 18, 19923,740 words Article Patients thought to have meningococcal disease who are treated with injected penicillin before admission to the hospital may be more likely to survive than those who are not. Patients infected with meningococcal bacteria...

• Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil

  Authors:Marcia de Cantuaria Tauil, Cleidiane Santos Rodrigues de Carvalho, Ataiza Cesar Vieira, and Eliseu Alves WaldmanFrom:The Brazilian Journal of Infectious Diseases (Vol. 18, Issue 4) Peer-Reviewed

  July-August 20144,013 words Report 1600LObjectives: To analyze the behavior of meningococcal disease in the Federal District, Brazil, from 2005 to 2011, and to assess the direct impact of the meningococcal serogroup C conjugate vaccine. Methods: A...

• ACIP okays MCV4

  Author:Dorothy L. PennachioFrom:Patient Care (Vol. 39, Issue 6) Peer-Reviewed

  June 2005162 words Brief article The CDC's Advisory Committee on Immunization Practices has added the quadrivalent meningococcal conjugate vaccine, MCV4 (Menactra), to routine childhood and adolescent immunization schedules. The new vaccine is...

• New products for 2005: this year's roundup looks at innovations in wound care, hand sanitizers, otoscopy, and vision screening. It also considers helpful online resources--and a peek into a virtual time capsule of technology

  Author:Andrew J. SchumanFrom:Contemporary Pediatrics (Vol. 22, Issue 12) Peer-Reviewed

  Dec. 20053,943 words Article We do live in interesting times. In 2005, hurricanes devastated America's Gulf Coast, the space shuttle returned to space, gasoline and crude oil prices hit an all-time high, and new cars became available to American...

• Meningococcal disease, serogroup W135, Burkina Faso : Preliminary report, 2002

  From:Weekly Epidemiological Record

  May 3, 2002993 words Brief article Background The major global burden of meningococcal disease is associated with cyclic large-scale epidemics in the African "meningitis belt", with peaks occurring during the dry season between November and April. One...

• Meningococcal disease, Uganda/Meningococcie, Ouganda

  From:Weekly Epidemiological Record (Vol. 81, Issue 5)

  Feb. 3, 2006213 words Brief article 1740LFrom 28 December 2005 to 23 January 2006, 163 suspected cases of meningococcal disease have been reported from the district of Nakapiripirit in north-eastern Uganda. Four cerebral spinal fluid specimens were positive...

• Treatment of meningococcal infection. (Current Topic)

  Authors:S.B. Welch and S. NadelFrom:Archives of Disease in Childhood (Vol. 88, Issue 7) Peer-Reviewed

  July 20035,257 words Article Aggressive early treatment of meningococcal disease can reduce mortality. This relies on prompt recognition and treatment of the complications of septicaemia and meningitis, appropriate ongoing intensive care where...

• Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review

  Authors:CA Goedvolk, IA von Rosenstiel, and AP BosFrom:Archives of Disease in Childhood (Vol. 88, Issue 10) Peer-Reviewed

  Oct. 20032,799 words Article Aim: To determine the incidence of immune complex associated complications (IAC) after severe meningococcal disease (SMD) in a group of Dutch children admitted to a paediatric intensive care unit (PICU). Methods:...

• Paternal smoking tied to meningococcal disease

  Author:MICHAEL G. BURKEFrom:Contemporary Pediatrics (Vol. 17, Issue 10) Peer-Reviewed

  Oct. 2000153 words Brief article Parental smoking and socioeconomic environment strongly influence the risk of invasive meningococcal disease, a study in the Czech Republic shows. Investigators reported on 68 children younger than 15 years with...

• Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135

  Authors:Raymond S.W. Tsang, Chao Ming Tsai, Averil M. Henderson, Shaun Tyler, Dennis K.S. Law, Wendell Zollinger, et al.From:Canadian Journal of Microbiology (Vol. 54, Issue 3) Peer-Reviewed

  Mar. 20085,100 words Article 1590LAbstract: We described 2 unusual Neisseria meningitidis strains isolated from epidemiologically unrelated invasive meningococcal disease cases in Ontario, Canada. Both isolates have features typical of serogroup Y N....

• Evaluation of the national surveillance system for invasive meningococcal disease, Italy, 2015-2018.

  Authors:Xanthi D. Andrianou, Flavia Riccardo, Maria Grazia Caporali, Cecilia Fazio, Arianna Neri, Paola Vacca, et al.From:PLoS ONE (Vol. 16, Issue 1) Peer-Reviewed

  Jan. 8, 20215,082 words Report 1520LEnhanced laboratory-based surveillance of invasive meningococcal disease (IMD) in Italy was only assessed indirectly by numerically comparing surveillance data cases with hospital discharge records (HDR). In this study,...

• CNS infections - 30 minutes to act

  Authors:Jordan D. Lipton, W. Michael Scheld, and Allan R. TunkelFrom:Patient Care (Vol. 30, Issue 10) Peer-Reviewed

  May 30, 19964,091 words Article Bacterial meningitis and herpes infections that affect the central nervous system, such as encephalitis, require immediate diagnosis and care to prevent death or severe complications. Factors to differentiate the...

• Structures of NHBA elucidate a broadly conserved epitope identified by a vaccine induced antibody

  Authors:Martina Maritan, Daniele Veggi, Roberta Cozzi, Lucia Dello Iacono, Erika Bartolini, Paola Lo Surdo, et al.From:PLoS ONE (Vol. 13, Issue 8) Peer-Reviewed

  Aug. 22, 201810,135 words Report 1660LNeisserial heparin binding antigen (NHBA) is one of three main recombinant protein antigens in 4CMenB, a vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B. NHBA is...